[ORGANIZATION]

TGA

Featured in 1 tracked story · first seen about 7 hours ago

Situations

[ACTIVE] [HEALTH] [GB] [AU] [HR]

Global safety concerns regarding GLP-1 weight loss drugs

2 clusters · 10 sources · last updated about 8 hours ago

Latest: Weight loss drugs linked to serious side effects and vision loss

Health authorities are monitoring a surge in reported adverse reactions and deaths linked to GLP-1 receptor agonists used for weight loss and diabetes, including semaglutide, tirzepatide, and liraglutide. Initial report